Recurrent Liver Cancer: Reconceptualization and Reevaluation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Recurrent Liver Cancer: Reconceptualization and Reevaluation — Stella

Recruiting

Back to Recurrent Liver Cancer trials

Trial locations(1 site)

China

The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu

Key details

Sponsor

Nanjing Medical University

Enrollment target

~300 participants

Started

July 2024

Primary completion

August 2026

Age range

18 Years – 75 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov